XORTX Therapeutics Inc. (XRTX)
Upgrades & Downgrades
Latest XRTX news
Why Are XORTX Therapeutics Shares Skyrocketing Today?
13 July 2022
XORTX Therapeutics Inc (NASDAQ: XRTX) has announced topline results from Part 1 of the three-part Pharmacokinetics Bridging Study – XRX-OXY-101. The data showed a substantial increase in oral bioavail...
XORTX Therapeutics (XRTX) Stock: Why It Skyrocketed Over 90% Today
13 July 2022
The stock price of XORTX Therapeutics Inc (NASDAQ: XRTX) skyrocketed by over 90% pre-market today. This is why.
XORTX to Present at BIO International Convention 2022
13 June 2022
CALGARY, Alberta, June 13, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focuse...
Here's Why XORTX Therapeutics Shares Are Rising
23 March 2022
XORTX Therapeutics (NASDAQ: XRTX) shares are trading higher by 54.6% at $1.87 after the company announced the submission of a Patent Cooperation Treaty patent application seeking international patent ...
XORTX Therapeutics Announces Closing of US$12 Million Public Offering
15 October 2021
CALGARY, Alberta, Oct. 15, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX | NASDAQ: XRTX), a pharmaceutical therapeutics company focused on developing innovative...